Spectral AI, Inc. (MDAI)
1.35
0.00 (0.00%)
USD |
NASDAQ |
Nov 18, 16:00
1.345
0.00 (0.00%)
After-Hours: 20:00
Spectral AI Gross Profit Margin (Quarterly) : 27.24% for Sept. 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 27.24% |
| June 30, 2026 | 31.58% |
| March 31, 2026 | 50.79% |
| December 31, 2025 | 39.78% |
| September 30, 2025 | 42.75% |
| June 30, 2025 | 45.21% |
| March 31, 2025 | 47.23% |
| December 31, 2024 | 44.03% |
| September 30, 2024 | 44.87% |
| Date | Value |
|---|---|
| June 30, 2024 | 44.32% |
| March 31, 2024 | 46.55% |
| December 31, 2023 | 46.08% |
| September 30, 2023 | 42.79% |
| June 30, 2023 | 42.13% |
| March 31, 2023 | 42.95% |
| December 31, 2022 | 41.14% |
| September 30, 2022 | 45.85% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Co-Diagnostics, Inc. | -85.83% |
| Fractyl Health, Inc. | -- |
| NovelStem International Corp. | -- |
| IGC Pharma, Inc. | 6.10% |
| Omnicell, Inc. | 44.77% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -58.62% |
| Return on Invested Capital | -429.1% |
| Profit Margin (Quarterly) | -128.0% |
| Operating Margin (Quarterly) | -138.9% |
| Return on Net Operating Assets | -253.9% |